NAAA
DGX icon

New Age Alpha Advisors’s Quest Diagnostics DGX Stock Holding History

New Age Alpha Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3K Buy
124
+23
+23% +$4.47K ﹤0.01% 745
2025
Q4 		$17.5K Buy
+101
New +$18.4K ﹤0.01% 749

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

New Age Alpha Advisors's DGX Position: Q1 2026 in Review

New Age Alpha Advisors increased its Quest Diagnostics (DGX) stake by 23% in Q1 2026, buying an estimated $4.47K and bringing the position to 124 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

New Age Alpha Advisors first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • New Age Alpha Advisors held 124 shares of Quest Diagnostics worth $24.3K as of Q1 2026.
  • New Age Alpha Advisors bought 23 Quest Diagnostics shares in Q1 2026, an estimated $4.47K.
  • Quest Diagnostics made up ﹤0.01% of New Age Alpha Advisors's portfolio in Q1 2026, its #745 holding.
  • New Age Alpha Advisors first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.